Chronic Pain Market Developments and Growth Opportunities Across 2026–2030
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Much Is The Chronic Pain Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?
The chronic pain market size has experienced robust growth in recent years. Projections indicate a rise from $84.66 billion in 2025 to $91.67 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.3%. Historically, this expansion has been driven by factors such as the increasing prevalence of chronic diseases, a rising incidence of neuropathic and musculoskeletal pain, broader availability of pain medications, enhanced clinical recognition of chronic pain, and the expansion of pain clinics.
The chronic pain market is anticipated to experience substantial growth in the upcoming years, with projections indicating it will reach $127.4 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.6%. This expansion throughout the forecast period is driven by factors such as increasing demand for personalized pain treatments, the rising adoption of bioelectronic devices, the broadening scope of telehealth-based pain services, a stronger focus on alternatives to opioids, and enhanced investment in pain research. Significant trends during this period are expected to include the wider implementation of multidisciplinary pain care models, an increased utilization of neuromodulation devices, a growing preference for non-opioid drug therapies, the expansion of home-based pain management solutions, and improved integration of digital health platforms.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11970&type=smp
What Drivers Are Influencing The Chronic Pain Market?
The widespread occurrence of individuals suffering from chronic pain is anticipated to drive the expansion of the chronic pain market. These patients are defined as those enduring pain that continues for an extended duration, usually more than three months, or beyond the typical recovery time. This high frequency of chronic pain sufferers fuels the chronic pain market’s expansion, given that the rising need for effective pain management therapies, such as drugs and medical equipment, opens avenues for industrial innovation and progress. For example, reports from June 2024 by the Australian Institute of Health and Welfare, an Australian government body, indicated that approximately 4.0 million Australians (16% of the population) were affected by back issues in 2022. By 2023, back problems had escalated to become the third leading contributor to disease burden, accounting for 4.3% of the nation’s total disease burden. Furthermore, a February 2024 publication from the US-based Institute for Health Metrics and Evaluation, a public health agency and research institution, projected global neck pain cases to reach 269 million by 2050 (with an estimated range of 219 to 322 million). Consequently, the widespread presence of chronic pain patients is a primary force behind the expansion of the chronic pain market.
What Major Segment Divisions Exist Within The Chronic Pain Market?
The chronic pain market covered in this report is segmented –
1) By Product: Drug, Devices
2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications
3) By End User: Hospitals, Clinics, Research Organization
Subsegments:
1) By Drug: Non-Opioid Analgesics, Opioids, Antidepressants, Anticonvulsants, Topical Analgesics, Corticosteroids
2) By Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Units, Spinal Cord Stimulators, Intrathecal Drug Delivery Systems, Heat And Cold Therapy Devices, Bioelectronic Devices
Which Trends Are Shaping The Future Of The Chronic Pain Market?
Major entities operating within the chronic pain market are adopting a strategic partnership approach to launch a shared savings program for the management of chronic pain. Strategic partnerships involve a process where companies leverage each other’s strengths and resources to achieve mutual benefits and success. For instance, in August 2023, MOBĒ, a US-based digital health innovator company, partnered with Override Health, a US-based healthcare company. Through this collaboration, they aim to address the management of chronic pain by means of a shared savings program that combines their respective expertise. MOBĒ, as a health outcomes company, utilizes healthcare data analytics to inform its high-touch, one-to-one health coaching and medication management model. On the other hand, Override delivers an integrated program of virtual interdisciplinary care, neuroplasticity-centered coaching, and peer support to assist individuals with chronic pain in navigating the complexities of disconnected care.
Which Companies Are Leading Innovation In The Chronic Pain Market?
Major companies operating in the chronic pain market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Mitsubishi Chemical Group Corporation, GlaxoSmithKline plc., Eli Lilly and Company, AstraZeneca plc., Becton, Dickinson, and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Endo International plc., Noven Pharmaceuticals Inc., Anika Therapeutics Inc., Collegium Pharmaceutical Inc., Heron Therapeutics Inc., Paradigm Biopharmaceuticals Ltd., Braeburn Inc., Taiwan Liposome Company Ltd., Axial Healthcare, AcelRx Pharmaceuticals Inc., Centrexion Therapeutics Corp., Vertanical GmbH, IKI Health Group, Tonix Pharmaceuticals Inc., Paperplane Therapeutics
Read the full chronic pain market report here:
https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report
Which Regions Are Expected To Experience Rapid Expansion In The Chronic Pain Market?
North America was the largest region in the chronic pain market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Chronic Pain Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=11970&type=smp
Browse Through More Reports Similar to the Global Chronic Pain Market 2026, By The Business Research Company
Virtual Reality Vr In Medical Simulation Global Market Report
Virtual Reality Software Global Market Report
https://www.thebusinessresearchcompany.com/report/virtual-reality-software-global-market-report
Virtual Reality Vr Fitness Game Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
